Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS)

PURPOSE: Autoimmune lymphoproliferative syndrome (ALPS) is a non-malignant genetic disorder of lymphocyte homeostasis with defective Fas-mediated apoptosis. Current therapies for ALPS primarily target autoimmune manifestations with non-specific immune suppressants with variable success thus highligh...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Immunol
Autors principals: Yokoyama, Seiji, Perera, Pin-Yu, Terawaki, Seigo, Watanabe, Nobumasa, Kaminuma, Osamu, Waldmann, Thomas A., Hiroi, Takachika, Perera, Liyanage P.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780245/
https://ncbi.nlm.nih.gov/pubmed/26453583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-015-0203-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars